Skip to main content
. 2022 Jul 8;13:892535. doi: 10.3389/fgene.2022.892535

FIGURE 2.

FIGURE 2

The diagnostic and prognostic analysis Of DLGAP5. (A) High DLGAP5 had worse overall survival (OS) for bladder cancer patients (p = 0.01, HR = 1.48). (B) The bladder cancer patients with high expression of DLGAP5 had worse disease specific survival (DSS) (p = 0.006, HR = 1.66). (C) The bladder cancer patients with high expression of DLGAP5 had worse progress free interval (DFI) (p = 0.007, HR-1.52). (D) The diagnostic analysis of DLGAP5 in bladder cancer patients. the area under the ROC curve (AUC) was 0.913, CI: 0.850–0.976. When the p < 0.05, the result was regarded as statistical significance.